Another thread prompted me to search in the scientific literature for the latest articles re dmt, and I found this little recent gem:
In a nutshell, after the discovery that dmt is a ligand for the intracellular sigma-1 receptor, this paper shows that progesterone antagonises the cellular effects that dmt exerts when it binds to sigma-1 receptor. Progesterone, one of the major reproductive hormones is also a ligand for the sigma-1 receptor. This thickens the plot and it may be relevant to female users of dmt. Insofar, the relevance of dmt acting on the sigma-1 receptor is unclear. We really do not know what this means when it comes to the effects of dmt, especially when we refer to its psychoactive effects. But whatever (psychoactive) effect (if any!) dmt exerts through the sigma-1 receptor, these are abolished by progesterone. It must be mentioned that the study was performed in vitro using cultured human cells, so despite the importance of these results it is essential not to overemphasize.
For me the most striking part (as I specialize in female reproductive endocrinology) is the effect of progesterone. This is where I'd like the input of the ladies of the Nexus on this issue. Progesterone, the prime hormone of pregnancy ("pro-" as in favouring, "-gesterone" as in gestation, pregnancy) is secreted after the day 14 of the menstrual cycle (i.e. after ovulation) and progressively rises till till it drops on the menstrual bleeding. I wonder whether the women of the Nexus get a different experience when they smoke or take orally dmt during the last days of their cycle before their period. By different effects I mean things that may include from poor experience outcomes to elevated/reduced bodily effects(e.g. heartbeating) to mindset( e.g. more/less calm state) etc.
Any input would be greatly appreciated!
(I am not going to attach the paper yet since it can only be found in its draft submission format, will do so when it gets properly formatted to publication standards.)Johannessen M, Fontanilla D, Mavlyutov T, Ruoho AE, Jackson MB.Antagonist Action of Progesterone at Sigma Receptors in the Modulation of Voltage-Gated Sodium Channels.Am J Physiol Cell Physiol. 2010 Nov 17.
Sigma receptors are integral membrane proteins that have been implicated in a number of biological functions, many of which involve the modulation of ion channels. A wide range of synthetic ligands activate sigma receptors, but endogenous sigma receptor ligands have proven elusive. One endogenous ligand, dimethyltryptamine (DMT), has been shown to act as a sigma receptor agonist. Progesterone and other steroids bind sigma receptors but the functional consequences of these interactions are unclear. Here we investigated progesterone binding to sigma-1 and sigma-2 receptors and evaluated its effect on sigma receptor-mediated modulation of voltage-gated Na+ channels. Progesterone binds both sigma receptor subtypes in liver membranes with comparable affinities and blocks photolabeling of both subtypes in HEK293 cells that stably express the human cardiac Na(+) channel Nav1.5. Patch clamp recording in this cell line tested Na(+) current modulation by the sigma receptor ligands ditolylguanidine, PB28, (+)SKF10047, and DMT. Progesterone inhibited the action of these ligands to varying degrees, and some of these actions were reduced by sigma-1 receptor knock-down with small interfering RNA. Progesterone inhibition of channel modulation by drugs was consistent with stronger antagonism of sigma-2 receptors. By contrast, progesterone inhibition of channel modulation by DMT was consistent with stronger antagonism of sigma-1 receptors. Progesterone binding to sigma receptors blocks sigma receptor mediated modulation of a voltage-gated ion channel, and this novel membrane action of progesterone may be relevant to changes in brain and cardiovascular function during endocrine transitions.
In a nutshell, after the discovery that dmt is a ligand for the intracellular sigma-1 receptor, this paper shows that progesterone antagonises the cellular effects that dmt exerts when it binds to sigma-1 receptor. Progesterone, one of the major reproductive hormones is also a ligand for the sigma-1 receptor. This thickens the plot and it may be relevant to female users of dmt. Insofar, the relevance of dmt acting on the sigma-1 receptor is unclear. We really do not know what this means when it comes to the effects of dmt, especially when we refer to its psychoactive effects. But whatever (psychoactive) effect (if any!) dmt exerts through the sigma-1 receptor, these are abolished by progesterone. It must be mentioned that the study was performed in vitro using cultured human cells, so despite the importance of these results it is essential not to overemphasize.
For me the most striking part (as I specialize in female reproductive endocrinology) is the effect of progesterone. This is where I'd like the input of the ladies of the Nexus on this issue. Progesterone, the prime hormone of pregnancy ("pro-" as in favouring, "-gesterone" as in gestation, pregnancy) is secreted after the day 14 of the menstrual cycle (i.e. after ovulation) and progressively rises till till it drops on the menstrual bleeding. I wonder whether the women of the Nexus get a different experience when they smoke or take orally dmt during the last days of their cycle before their period. By different effects I mean things that may include from poor experience outcomes to elevated/reduced bodily effects(e.g. heartbeating) to mindset( e.g. more/less calm state) etc.
Any input would be greatly appreciated!